ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

Curcumin targets miR-134-5p to suppress the progression of colorectal cancer through regulating the CDCA3/CDK1 pathway.

Fu Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.